Answers are grounded in this paper and cite their sources.
Narrative review reveals confounding factors in measuring neurohypophysial hormone release in vivo, suggesting target-organ responses frequently misrepresent direct endocrine activity.
A wide variety of stimuli has been described which release neurohypophysial hormones under experimental conditions in vivo (see the reviews of Denamur, 1965, and Heller & Ginsburg, 1966). In much of the work reviewed, however, the release of vasopressin and/or oxytocin was assessed by its effect on a target organ in the stimulated animal. Under these conditions there may be some doubt as to whether the effect of the stimulus on the target organ is entirely caused by vasopressin or oxytocin. Other substances, released by the same stimulus, might either mask the effect of the released hormone, imitate its effect or block its release. For example, it has been shown that adrenaline, which might be released in addition to the neurohypophysial hormones by some of the stimuli used, may mask the effects of oxytocin on the mammary gland and inhibit the release of oxytocin from the neurohypophysis (Cross, 1953, 1955a, b). It has also been shown (O' Connor & Verney, 1945; Verney, 1947; Duke & Pickford, 1951) that adrenaline can inhibit the release of vasopressin and that it can itself cause an antidiuresis. Other endogenous substances may also cause an antidiuresis, for example, bradykinin, angiotensin and substance P (Bisset & Lewis, 1962) but their activity is probably chiefly the result of cardiovascular effects. In addition many of the stimuli used to release vasopressin may cause fluctuations in blood pressure and this is likely to affect the rate of urine flow.
No takes yet. Share an insight, caveat, or question.
R. E. J. Dyball (1968) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: